Idelalisib
Jump to navigation
Jump to search
Idelalisib | |
---|---|
Term | Idelalisib |
Short definition | Idelalisib (i-deh-luh-LIH-sib) A drug used with rituximab to treat relapsed chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Idelalisib - (pronounced) (i-deh-luh-LIH-sib) A drug used with rituximab to treat relapsed chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Idelalisib blocks certain proteins that can help stop cancer cells from growing and kill them. It's a kind of kinase inhibitor. Also called cydelig
External links
- Medical encyclopedia article on Idelalisib
- Wikipedia's article - Idelalisib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski